36
Participants
Start Date
September 30, 2016
Primary Completion Date
June 21, 2017
Study Completion Date
June 21, 2017
AGN-195263
1 drop of AGN-195263 will be instilled in each eye twice daily.
Vehicle
1 drop of AGN-195263 vehicle (placebo) will be instilled in each eye twice daily.
Eye Doctors of Washington, Chevy Chase
Cornerstone Eye Care, LLC, High Point
Carolina Macula and Retina, Mt. Pleasant
Eye Care Centers Management, Inc. dba Clayton Eye Center, Morrow
Argus Research at Cape Coral Eye Center, Cape Coral
Sarasota Retina Institute, Sarasota
Nashville Vision Associates, LLC, Nashville
Taustine Eye Center, Louisville
University Hospitals of Cleveland, Cleveland
The Eye Centers of Racine and Kenosha, Racine
Comprehensive Eye Care, Washington
Ophthalmology Consultants, Ltd, St Louis
Mercy Medical Research Institute, Springfield
Robert Cizik Eye Clinic, Houston
Houston Eye Associates, Kingwood
Brazosport Eye Institute, Lake Jackson
The Eye Clinic of Texas, an affiliate of Houston Eye Associates, League City
R and R Eye Research, LLC, San Antonio
DCT- Shah Research, LLC dba Discovery Clinical Trials, Mission
Centennial Eye and Cosmetic Associates, Centennial
Specialty Eye Care, Parker
Stacy R. Smith, M.D., P.C., Salt Lake City
Arizona Eye Center, Chandler
Montebello Medical Center, Inc., Montebello
Eye Research Foundation, Newport Beach
Clearsight, Fullerton
Orange County Ophthalmology Medical Group, Garden Grove
North Bay Eye Associates, Petaluma
Martel Eye Medical Group, Rancho Cordova
Lead Sponsor
Allergan
INDUSTRY